Skip to main content
Clinical Trials/NCT05094375
NCT05094375
Unknown
Not Applicable

Vaginal Misoprostol 600 mcg and 800 mcg In Medical Treatment of First Trimester Missed Miscarriage: A Randomized Controlled Trial.

hany farouk1 site in 1 country200 target enrollmentNovember 1, 2021

Overview

Phase
Not Applicable
Intervention
Vaginal Misoprostol 600 mcg
Conditions
Miscarriage
Sponsor
hany farouk
Enrollment
200
Locations
1
Primary Endpoint
Completeness of abortion
Last Updated
4 years ago

Overview

Brief Summary

Efficacy of vaginal misoprostol 600 Mg versus 800 Mg in termination of the first trimester missed abortion were assist

Detailed Description

In women with first trimetric-missed miscarriage, vaginal misoprostol in the achievement of successful miscarriage so our aim was to compare the effectiveness of vaginal misoprostol 600 Mg versus 800 Mg for medical treatment of the first trimester missed miscarriage.

Registry
clinicaltrials.gov
Start Date
November 1, 2021
End Date
June 30, 2023
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
hany farouk
Responsible Party
Sponsor Investigator
Principal Investigator

hany farouk

Clinical Professor

Aswan University Hospital

Eligibility Criteria

Inclusion Criteria

  • All women above 18 years of age
  • Less than 12 weeks of gestation.
  • Pregnancy is confirmed by pregnancy test or ultrasound scan.
  • missed abortion
  • Normal general and gynecological examination.

Exclusion Criteria

  • Hemodynamically unstable.
  • Suspected sepsis with temperature 38 °C.
  • Concurrent medical illness e.g. hematological, cardiovascular, thromboembolism,
  • respiratory , recent liver disease, or pruritus of pregnancy.
  • Presence of intrauterine contraceptive device (IUCD).
  • Suspect or proven ectopic pregnancy.
  • Failed medical or surgical evacuation before the presentation.
  • Known allergy to misoprostol.

Arms & Interventions

Vaginal Misoprostol 600 mcg

All patients will receive three doses of vaginal misoprostol every four hours. The first dose of misoprostol 600 mcg will be administrated at the hospital. Then the patient will be observed for 1 hour for any immediate adverse reaction Clear instructions about the method and timing of the second dose will be given upon sending home. * Two doses of misoprostol 600 mcg each (3 tablets of 200 mcg per dose). * Paracetamol, eight hourlies, will be provided as analgesic or antipyretic. * A specimen bottle to collect the POC if passed out. * Two pairs of disposable gloves. * Pre-filled histopathological examination form to be sent to the laboratory together with the products of conception

Intervention: Vaginal Misoprostol 600 mcg

Vaginal Misoprostol 800 mcg

All patients will receive three doses of vaginal misoprostol every four hours. The first dose of misoprostol 800 mcg will be administrated at the hospital. Then the patient will be observed for 1 hour for any immediate adverse reaction Clear instructions about the method and timing of the second dose will be given upon sending home. * Two doses of misoprostol 800 mcg each (four tablets of 200 mcg per dose). * Paracetamol, eight hourlies, will be provided as analgesic or antipyretic. * A specimen bottle to collect the POC if passed out. * Two pairs of disposable gloves. * Pre-filled histopathological examination form to be sent to the laboratory together with the products of conception

Intervention: Vaginal Misoprostol 800 mcg

Outcomes

Primary Outcomes

Completeness of abortion

Time Frame: 7 days

expulsion of Products of conception by visual inspection

Secondary Outcomes

  • Pain resulting from the procedure(7 days)
  • Bleeding pattern following treatment(7 days)
  • Additional uterotonic used(14 days)
  • Successful medical abortion(14 days)

Study Sites (1)

Loading locations...

Similar Trials